Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2015

View Archived Issues

AmorChem licenses mucoadhesive nanoparticle technology from University of Waterloo

JDRF supports Janssen's disease interception approach to prevent onset of type 1 diabetes

Cidara Therapeutics completes financing round to support pipeline

Cipla's U.K. subsidiary enters into a joint venture with Cooper Pharma and PHI

DARPA awards contract to SRI Biosciences to discover synthetic polymer drugs

Novigenix acquires colon cancer blood test Colox

AC Immune receives MJFF grant to develop PET tracer for Parkinson's disease diagnosis

Clinigen opens global access program for ceftazidime/avibactam

Epitarget and IC Contrast complete merger

Promising data revealed on a novel Ebola vaccine candidate

Novavax begins phase I Ebola vaccine trial

Horizon Pharma submits IND application for Actimmune for Friedreich's ataxia

Shanghai Institute Materia Medica discloses new alpha1A-adrenoreceptor antagonists

Vernalis and Servier patent novel Bcl-2 inhibitors

Novartis reports new apelin receptor agonists

New FXIa inhibitors designed by Bayer

Capsule depolymerase EnvD shows efficacy in an inhalation model of anthrax

Scientists at Instituto Italiano di Tecnologia disclose FAAH inhibitors

FDA approves lenvatinib for thyroid cancer

First in vivo results presented of novel ricin and Shigatoxin trafficking inhibitors

Lassa fever recombinant vaccine shows enhanced immunogenicity in mice

FDA accepts NDA for Pfizer's abuse-deterrent formulation of oxycodone

FDA approves sNDA for rufinamide in Lennox-Gastaut syndrome in children aged 1-4 years

Novartis's LCZ-696 to receive FDA priority review for heart failure

N9-GP shows efficacy in pediatric hemophilia B patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...